The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
Open accessAbstract
The growing availability of more effective therapies has contributed to an increased survival of patients with breast cancer. In hormone receptor-positive early disease, increased survival is strongly correlated with the use of adjuvant endocrine therapy, but this therapy can cause side-effects that have major consequences in terms of treatment adherence and patients' quality of life. In premenopausal breast cancer survivors, these side-effects might be even more prominent due to the abrupt suppression of oestrogen associated with the most intense endocrine therapies. An important ambition of cancer care in the 21st century is to recover pre-cancer quality of life and emotional and social functions, which is only possible through the mitigation of the side-effects of anticancer treatments. This Review presents a comprehensive summary of the efficacy and safety data of the available interventions (hormonal and non-hormonal pharmacological strategies, non-pharmacological approaches, and complementary and alternative medicine) to control selected side-effects associated with adjuvant endocrine therapy (hot flashes, sexual dysfunction, weight gain, musculoskeletal symptoms, and fatigue), providing updated, evidence-based approaches for their management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Howard-Anderson, J., Ganz, P. A., Bower, J. E., & Stanton, A. L. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr541 · Cited by 830
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., LaVasseur, B. I., Barton, D. L., Novotny, P. J., Dakhil, S. R., Rodger, K., Rummans, T. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03403-6 · Cited by 737
Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2114-5 · Cited by 708
Megestrol acetate for the prevention of hot flashes.
Loprinzi, C. L., Michalak, J. C., Quella, S. K., O'Fallon, J. R., Hatfield, A. K., Nelimark, R. A., Dose, A. M., Fischer, T., Johnson, C., Klatt, N. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310602 · Cited by 500
Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors
Irwin, M. L., Cartmel, B., Gross, C. P., Ercolano, E., Li, F., Yao, X., Fiellin, M., Capozza, S., Rothbard, M., Zhou, Y., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1547 · Cited by 324
Elkins, G., Marcus, J., Stearns, V., Perfect, M., Rajab, M. H., Ruud, C., Palamara, L., & Keith, T. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6389 · Cited by 219
Abrahams, H. J. G., Gielissen, M. F. M., Donders, R. R. T., Goedendorp, M. M., van der Wouw, A. J., Verhagen, C. A. H. H. V. M., & Knoop, H. (2017) · Cancer · doi:10.1002/cncr.30815 · Cited by 165
Hummel, S. B., van Lankveld, J. J. D. M., Oldenburg, H. S. A., Hahn, D. E. E., Kieffer, J. M., Gerritsma, M. A., Kuenen, M. A., Bijker, N., Borgstein, P. J., Heuff, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.6021 · Cited by 162
Yoga and meditation for menopausal symptoms in breast cancer survivors—a randomized controlled trial
Cramer, H., Rabsilber, S., Lauche, R., Kümmel, S., & Dobos, G. (2015) · Cancer · doi:10.1002/cncr.29330 · Cited by 131
Marcus, A. C., Garrett, K. M., Cella, D., Wenzel, L., Brady, M. J., Fairclough, D., Pate‐Willig, M., Barnes, D., Powell Emsbo, S., Kluhsman, B. C., et al. (2010) · Psycho-Oncology · doi:10.1002/pon.1653 · Cited by 115
Cited by
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Vaz-Luis, I., Di Meglio, A., Havas, J., El-Mouhebb, M., Lapidari, P., Presti, D., Soldato, D., Pistilli, B., Dumas, A., Menvielle, G., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01958 · Cited by 65
“Particularly, patients should be educated to self-monitor changes in fatigue levels over time, encouraged to be attentive to symptoms that can herald the onset of persistent fatigue, and advised to seek medical help if a persistent deterioration of energy levels exists (Fig 2).(30-35) Finally, by highlighting the comp…”
BackgroundSelf-citationThe Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity
Papadopetraki, A., Giannopoulos, A., Maridaki, M., Zagouri, F., Droufakou, S., Koutsilieris, M., & Philippou, A. (2023) · Cancers · doi:10.3390/cancers15245856 · Cited by 34
Konara Mudiyanselage, S. P., Wu, Y.-L., Kukreti, S., Chen, C.-C., Lin, C.-N., Tsai, Y.-T., Ku, H.-C., Fang, S.-Y., Wang, J.-D., & Ko, N.-Y. (2023) · Breast Cancer · doi:10.1007/s12282-022-01413-6 · Cited by 22
“They expressed gratitude for the ability to mitigate menopausal and vaginal symptoms, thus improving their BI and self-esteem, maintaining their sexual desire, and continuing interactive, friendly relationships (in the case of young BC survivors), all of which contribute to their long-term sexual health [76, 77].”
BackgroundVerkooyen, R., Broers, N. J., & Dandachi-FitzGerald, B. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1378456 · Cited by 18
Metadata
- Authors
- Franzoi, M. A., Agostinetto, E., Perachino, M., Del Mastro, L., de Azambuja, E., Vaz-Luis, I., Partridge, A. H., & Lambertini, M.
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 22
- Issue
- 7
- Pages
- e303-e313
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W3153195366
- Cited by
- 290
- References
- 12
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. https://app.cochat.ai/papers/10.1016/s1470-2045(20)30666-5
- The paper
- Franzoi, M. A., Agostinetto, E., Perachino, M., Del Mastro, L., de Azambuja, E., Vaz-Luis, I., Partridge, A. H., & Lambertini, M. (2021). Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(20)30666-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.